The Right Tools to Manage Medically Billed Drugs

Our Medical Drug Management program delivers more personalized care, increased access to medications and greater efficiency for patients and plans.

SafeGuardRx Saved Enrolled Plans $4.3 Billion in 2019

In 2019, plans that participated in our SafeGuardRx® platform saw healthier outcomes for members, more savings, and the flexibility to do more with their benefit budget.

Ask the Pharmacist: How Can I Improve My Heart Health?

February is American Heart Month. Take a few moments to learn more - for your heart’s sake.

High Deductible Members Can Realize High Rewards

A Wholehearted Solution: Cardiovascular Care Value^SM

Express Scripts’ new Cardiovascular Care Value^SM program expands on our SafeGuardRx^® Cholesterol Care Value^SM program to holistically tackle the clinical and financial...

We Offered a Path to Lower Drug Prices And Gilead Listened

We're encouraged that Gilead Sciences is taking meaningful action to bring prices down for cash-paying customers.

Biosimilars in the U.S.: More Approvals But Not More Access

Biosimilars have the potential to significantly reduce treatment costs. We take a look at the growing biosimilar pathway.

How We Build a Formulary

When properly constructed, drug formularies are a crucial strategy for keeping prescription medications affordable while preserving access for the patients who need them.

INFOGRAPHIC: How Rare are Rare Diseases?

Accredo helps patients manage the unique complexities of a rare disease with best-in-class clinical care while supporting payers with appropriate management strategies.

An Affordable Alternative for Daraprim: $1 per Pill

Express Scripts and Imprimis Pharmaceuticals champion the needs of patients who can't pay $750 for a single pill.

MAC Pricing Keeps Generics Affordable

The market for purchasing drugs can be complex, but with MAC pricing, multi-sourced generic medications are kept as affordable as possible in the U.S.

$25 Million Targeting Early-Stage Health Care Innovation

Our multi-year commitment to Lewis & Clark Ventures specifically targets new techologies and companies with the potential to provide early acces to the next big ideas in health care.

Ensuring the Right Drug at the Right Price

Indication-specific pricing makes therapy more affordable and accessible for all patients by aligning payment for a drug with the value it delivers to a particular patient population.

The Rebate Debate

SmartShare Rx^SM gives employers and plan sponsors greater flexibility in how they use rebates savings to keep the benefit affordable.

Financial Assistance Programs Positively Impact Adherence

Patients with inflammatory conditions and multiple sclerosis can overcome barriers to taking their medications with the help of financial assistance programs.